SELLAS Life Sciences (SLS) Revenue (2012 - 2022)
SELLAS Life Sciences (SLS) posted quarterly Revenue of $1.0 million for Q1 2022, down 82.46% year-over-year from $5.7 million in Q1 2021, and down 47.37% quarter-over-quarter from $1.9 million in Q2 2021.
SELLAS Life Sciences (SLS) Revenue (2012 - 2022) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Revenue for 7 consecutive years, with $1.0 million the latest figure, recorded in Q1 2022.
- In Q1 2022, Revenue fell 82.46% year-over-year to $1.0 million; the TTM figure through Dec 2022 stood at $1.0 million (down 86.84% YoY), while the FY2022 annual figure was $1.0 million, down 86.84% from the prior year.
- Revenue retreated to $1.0 million in Q1 2022 per SLS's latest filing, from $1.9 million in the prior quarter.
- Across five years, Revenue topped out at $5.7 million in Q1 2021 and bottomed at $1.0 million in Q1 2022.
- Historically, Revenue has averaged $2.6 million across 3 years, with a median of $1.9 million in 2020.
- On a YoY basis, Revenue climbed as much as 82.46% in 2022 and fell as far as 82.46% in 2022.
- SELLAS Life Sciences' Revenue stood at $1.9 million in 2020, then changed by 0.0% to $1.9 million in 2021, then slumped by 47.37% to $1.0 million in 2022.
- Business Quant data shows SLS's Revenue at $1.0 million in Q1 2022, $1.9 million in Q2 2021, and $5.7 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.00 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 5.70 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Jun 30, 2015 | 3.38 Mn |
| Mar 31, 2015 | 2.75 Mn |
| Dec 31, 2014 | 3.20 Mn |
| Sep 30, 2014 | 1.62 Mn |
| Jun 30, 2014 | 2.33 Mn |
| Mar 31, 2014 | 2.17 Mn |
| Dec 31, 2013 | 3.20 Mn |
| Sep 30, 2013 | 1.62 Mn |
| Jun 30, 2013 | 2.33 Mn |
| Mar 31, 2013 | 2.17 Mn |
| Dec 31, 2012 | -1.17 Mn |
| Sep 30, 2012 | 1.17 Mn |